• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

ceo

  1. Worst CEO Stat News

    Pops landed a spot for the worst CEO in biopharma. He is a nice guy, but the company is tanking, the people that work there are outdated and their clinical is a little misleading. The staff there is not innovative and still stuck in the late 90’s on how things work. Benefits are average...
    • anonymous
    • Thread
    • ceo pops worst ceo
    • Replies: 12
    • Forum: Alkermes

  2. Merck announces management changes

    Merck creates two new executive positions; CCO and CMO. Adam Schechter, President of GHH becomes an advisor to Ken Frazier
    • anonymous
    • Thread
    • ceo chief commercial officer chief marketing officer executives frank clyburn global human health kenneth frazier management merck michael nally
    • Replies: 9
    • Forum: Merck

  3. Gilead CEO resigns, Q2 profit falls 40%

    Earnings slipped more than 40% in the second quarter of FY2018 for Gilead. The company updated that John F. Milligan will step down as CEO and President. https://news.alphastreet.com/gilead-sciences-q2-2018-earnings-results/
    • Anon News Reader
    • Thread
    • ceo earnings gilead
    • Replies: 2
    • Forum: Gilead Sciences

  4. 2 small biopharma CEOs that should be sacked

    Check this out from Seeking Alpha: https://www.google.com/amp/s/seekingalpha.com/amp/article/4133495-2-small-biopharma-ceos-sacked "I refer, of course, to Egalet (EGLT). It is hard to imagine a company that has done a better job of destroying shareholder value here in 2017 as the chart below...
    • Radieculous
    • Thread
    • bob radie ceo eglt fired sacked
    • Replies: 32
    • Forum: Egalet

  5. Dave Ricks taps several new chiefs

    New leadership for Finance, Research & Development and Manufacturing. Will the new leadership deliver? Also, two senior leaders to resign.
    • anonymous
    • Thread
    • ceo eli lilly
    • Replies: 2
    • Forum: Eli Lilly

  6. Will Kare Schultz revive Teva?

    After a seven month long search, Teva appoints Kare Schultz as its new CEO. Remember he had axed 1,000 people or 17% of Lundbeck's workforce when he was its CEO.
Top Bottom
Back